Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
BörsenkürzelPLRZ
Name des UnternehmensPolyrizon Ltd
IPO-datumOct 29, 2024
CEOMr. Tomer Izraeli
Anzahl der mitarbeiter1
WertpapierartOrdinary Share
GeschäftsjahresendeOct 29
AddresseHaTidhar St. 5
StadtRA'ANANA
BörseNASDAQ Capital Market Consolidated
LandIsrael
Postleitzahl- -
Telefon97293740120
Websitehttps://polyrizon-biotech.com/
BörsenkürzelPLRZ
IPO-datumOct 29, 2024
CEOMr. Tomer Izraeli
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten